Trial intelligence / Profile preview

Angiotensin 1-7 in metastatic or unresectable sarcomas

NCT01553539Phase 2Completed

Sponsor
Wake Forest University Health Sciences
Start
Oct 2009
Primary completion
Jan 2013
Countries
1
01

Overview

A Phase 2 trial of angiotensin-(1-7) in sarcoma, sponsored by Wake Forest University Health Sciences. Started Oct 2009; status: completed.

02

Drugs

angiotensin-(1-7)
03

Conditions

sarcoma

Beyond the preview

Go deeper on NCT01553539.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01553539.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call